| Value | ₹35.50 Cr |
|---|
NSE filing, NSE: TIRUPATI. Summary written from the filing by ALFA Finder's alert engine.
Shree Tirupati Balajee FIBC Ltd: key numbers
- Share price
- ₹287.00
- Market cap
- ₹290.7 Cr
- Revenue (annual)
- ₹202.9 Cr
- Net profit (annual)
- ₹2.84 Cr
- P/E (TTM)
- 102.2×Sector 45.0×
- Promoter holding
- 66.15%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shree Tirupati Balajee FIBC Ltd
All →Shree Tirupati Balajee FIBC H1 FY27 Results: Net Profit ₹2 Cr, Up 11.1% YoY
Shree Tirupati Balajee FIBC Ltd reported revenue from operations of ₹124.1 Cr (+29.5% YoY) and net profit of ₹2 Cr (+11.1% YoY) for H1 FY27.
- Key figure
- Net profit ₹2 Cr · +11.1% YoY
Shree Tirupati Balajee FIBC Board Meeting Date
Shree Tirupati Balajee FIBC Ltd intimated a board meeting on 4 Nov 2026 to consider half-yearly unaudited results. No financial figures are disclosed in this advance notice.
Shree Tirupati Balajee FIBC Annual General Meeting
Shree Tirupati Balajee FIBC Limited submitted minutes for its 17th Annual General Meeting held on September 25, 2026. Shareholders approved financial statements and director re-appointments.
Shree Tirupati Balajee FIBC Management Change
Shree Tirupati Balajee FIBC Limited announced the change in designation for Vinod Verma and the re-appointment of Yash Khemchandani and Binod Kumar Agarwal as directors.
Shree Tirupati Balajee FIBC Annual General Meeting
Shree Tirupati Balajee FIBC Limited held its 17th Annual General Meeting via video conferencing on September 25, 2026, to discuss and approve various business resolutions.
Shree Tirupati Balajee FIBC Annual General Meeting
Shree Tirupati Balajee FIBC Limited will hold its 17th Annual General Meeting on September 25, 2026. Key agenda items include director re-appointments and related party transaction approvals.
Other acquisition announcements
All →Aurobindo Pharma Acquisition
Aurobindo Pharma announced a board-approved proposal to merge two wholly owned subsidiaries, Auroactive Pharma into Apitoria Pharma, via NCLT scheme. No cash consideration; the share-exchange ratio issues 23,95,900 shares of Apitoria.
Choice International Acquisition
Choice International acquired 100% stakes in Truestock Universe and Quanthm Bit Works for Rs.10,000 each, entering digital/technology space. Its material subsidiary CCSPL also sold its entire stake in SKP Green Ventures, making it a step-down subsidiary.
Pajson Agro India Acquisition Worth ₹354.5 Cr
Pajson Agro's board approved acquiring 100% of Pacific Global FZCO for Rs 354.52 Crore via share swap. A preferential issue and EGM on December 4 follow.
- Value
- ₹354.5 Cr
Gujarat Fluorochemicals Acquisition Worth ₹600 Cr
Gujarat Fluorochemicals approved a Rs 600 Crore cash investment in its subsidiary GFCL EV Products, to be paid in tranches over FY 2026-27. The transaction is classed as a related-party deal and is not material.
- Value
- ₹600.0 Cr
- Execution
- FY 2026-27
Mafatlal Industries Acquisition Worth ₹0.25 Cr
Mafatlal Industries' board approved buying a 20% stake in its subsidiary PSPL from an existing shareholder for Rs. 25 lakh. The company's holding rises from 60% to 80%.
- Value
- ₹0.25 Cr
- Execution
- Within thirty (30) days
Physicswallah Acquisition Worth ₹0.03 Cr
Physicswallah will acquire 25,599 shares, or 12.25%, of subsidiary Utkarsh Classes for ₹2,55,990 under a fixed-price amendment. Its stake rises from 75.50% to 87.75%.
- Value
- ₹0.03 Cr
- Execution
- Three months